JA
John Aballi (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Exagen Inc. (XGN). The largest single filing was $270K of XGN (34,294 sh × $7.87, as filed), executed Oct 16. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$270K
shares × price, as filed
Last traded
Oct 16
Filed Oct 19
Median ADV $2.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $646K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
XGNRecent filings
XGNSALE
Exagen Inc.
View filing →
$270K34,294 sh × $7.87
Exec Oct 16
Filed Oct 19 · 4:52 PM ET XGNSALE Exagen Inc. View filing → $376K
31,787 sh × $11.82
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET